Consistently, genetic variants of DICER1 have been found to modulate the risk of gastric cancer [97], endocrine tumors [98], ovarian cancer [99], testicular germ-cell tumors [98], and neurofibromatosis [100], and have been found to be associated with head and neck cancer recurrence [98] and ovarian cancer prognosis [98]. The gene discussed is DICER1; the disease is gastric cancer.